MedTrace Logo

Pupillometry and Pain Thresholds Patients Substituted by Methadone and Buprenorphine

NCT01560442 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2013-01-14

No results posted yet for this study

Summary

The purpose is to study the relation between pupillary diameter measured under scotopic conditions, and the pain thresholds measured at the time of peak and residual effect of methadone/buprenorphine in opiate-dependent patients following a substitution program.

Conditions

  • Opiate Dependent
  • Previous Illicit Drug Use

Interventions

DRUG

Buprenorphine and Methadone Hydrochloride

To study the relation between pupillary diameter measured under scotopic conditions, and the pain thresholds measured at the time of peak and residual effect of methadone / buprenorphine in opiate-dependent patients following a substitution program.

Sponsors & Collaborators

  • CSAPA ANPAA 63

    collaborator UNKNOWN

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Nicolas AUTHIER · University Hospital, Clermont-Ferrand

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-07-31
Completion
2013-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01560442 on ClinicalTrials.gov